I’m most excited about is the opportunity to enhance patient and research site’s mobile experience.
COSTA MESA, Calif. (PRWEB) February 21, 2018
With over 20 years of experience in web and mobile app development, industry professional Stace Baal joines StudyKIK, the fastest growing patient recruitment company in the clinical trial industry. As Chief Technology Officer, Stace will lead StudyKIK in developing new, innovative and exciting applications for patient enrollment and retention. Stace’s breadth of technology from previous roles, like eHarmony.com, will build on an already successful technology platform to add stability, security and innovation to the engineering team.
“I’m excited to join StudyKIK’s innovative and talented team to lead technology and scale our application to meet the explosive growth demands of the company. StudyKIK will leverage the latest in application architecture, big data and mobile to grow our platform to lead the industry in patient recruitment and retention software. I see great opportunity to innovate and disrupt in the 5 billion dollar patient recruiting and retention space, technology will play an important role in bringing biotech and pharmaceutical solutions to market in less time and with more efficiency. “ -Stace Baal, CTO at StudyKIK
Prior to StudyKIK, Stace worked as Director of Engineering for over 10 years at well established dating website, eHarmony.com, building large teams of engineers, focused on consumer facing web and native mobile applications. A big advocate of data, especially when it relates to system reliability and monitoring solutions, Stace single-handedly setup and configured intricate monitoring solutions across eHarmony’s entire core codebase.
“We are thrilled to have Stace join our team! There is so much to build in the clinical trial industry and I am excited to see the innovations that Stace will bring! StudyKIK has millions of patient data points in clinical trials and thousands of data points on specific protocols that we have enrolled over the last 4 years. I see a huge opportunity in developing smart, machine-learned solutions using our platform. What I’m most excited about is the opportunity to enhance patient and research site’s mobile experience. Stace’s experience in mobile technology will be a breath of fresh air to this industry in producing a mobile experience for investigators, coordinators, sponsors and patients that no one has ever seen.” - Jerome Chiaro, VP Clinical Site Operations at StudyKIK
In 2017 StudyKIK launched their Patient Messaging Suite, the industry’s first HIPAA compliant 2-way text messaging and email platform for research sites to communicate with patients. Upcoming developments include technology that will allow patients to be enrolled into clinical trials globally faster than ever before.
StudyKIK’s focus is to expand the awareness of clinical trials to patient groups globally on social media while providing research sites with technology to easily enroll clinical trial volunteers. To learn more about StudyKIK, visit StudyKIK.com.
StudyKIK is a website where patients can find and sign up for clinical trials with ease. These patients find StudyKIK through our robust social community pages on Facebook, Twitter, Instagram, Pinterest, and more! Every clinical trial listed on StudyKIK benefits from the millions of patients across social media and search engines in almost every therapeutic area in all phases including: Respiratory, Immunology, CNS, Cardiology, Endocrinology, Gastroenterology, Healthy Volunteer, Dermatology, Rheumatology, Urology, and much more! Patient traffic is filtered using our proprietary targeting software so that only patients in a geographic radius of your site that match your inclusion & exclusion criteria will find your clinical trial.